Log in to save to my catalogue

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS o...

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5609185

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer

About this item

Full title

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer

Publisher

Athens: Editorial Academy of the International Journal of Oncology

Journal title

International journal of oncology, 2012-06, Vol.40 (6), p.2013-2021

Language

English

Formats

Publication information

Publisher

Athens: Editorial Academy of the International Journal of Oncology

More information

Scope and Contents

Contents

This study aimed to analyze expression of Müllerian inhibiting substance type II receptor (MISRII) protein and mRNA in cervical neoplasia, to demonstrate the growth inhibition of cervical cancer cells by administration of highly purified recombinant human Müllerian inhibiting substance (MIS) and, furthermore, to evaluate the clinical significance o...

Alternative Titles

Full title

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5609185

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5609185

Other Identifiers

ISSN

1019-6439

E-ISSN

1791-2423

DOI

10.3892/ijo.2012.1370

How to access this item